Skin Disease
Reports outline skin disease study results from University of Pennsylvania
Published in Pharma Investments, Ventures and Law Weekly, November 15th, 2009
'Lenalidomide, a derivative of thalidomide, is an immunomodulatory agent introduced in 2004 for the treatment of multiple myeloma in combination with dexamethasone. it is also indicated for the treatment of myelodysplastic syndrome and is currently under investigative use for metastatic melanoma. We present a case of neutrophilic dermatosis involving predominantly the lower extremities in a patient receiving lenalidomide therapy for multiple myeloma. (J Am Acad Dermatol 2009;61:709-10.)' This article was prepared by Pharma Investments, Ventures & Law Weekly editors from staff and other reports. Copyright 2009, Pharma Investments, Ventures & Law Weekly via NewsRx.com.
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- AARP Idaho
AARP Says Idaho on Crash Course With Health Care Disaster - Addus HomeCare
Addus HomeCare Corporation Prices Initial Public Offering - Allergan, Inc.
Allergan Announces Victory in Brimonidine Patent Infringement Case - Amazon Defense Coalition
Amazon Defense Coalition: Chevron Admits Its Lawyers Present at Key Meeting with Ecuador Man Who Taped Video Scandal - American CareSource Holdings, Inc.
American CareSource To Present at Oppenheimer Healthcare Conference - Americans for Tax Reform
Taxpayer Group Launches Petition to Ask Sen. Ben Nelson to Keep His Pledge - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
